Publication details

Ranibizumab

Authors

KOLÁŘ Petr

Year of publication 2007
Type Article in Periodical
Magazine / Source Farmakoterapie
MU Faculty or unit

Faculty of Medicine

Citation
Field ORL, ophthalmology, stomatology
Keywords ranibizumab; age related macular degeneration; vascular endothelial growth factor; intraocular injection into vitreous humour
Description Ranibizumab is recombinant humanized monoclonal fragment of vascular endothelial factor antibody (VEGF). Its application is indicated in treatment of wet form of age related macular degeneration (AMD).

You are running an old browser version. We recommend updating your browser to its latest version.

More info